EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 390 filers reported holding EXELIXIS INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,402,770 | +14.3% | 64,200 | 0.0% | 1.14% | +44.9% |
| Q2 2023 | $1,226,862 | -1.5% | 64,200 | 0.0% | 0.78% | -7.5% |
| Q1 2023 | $1,246,122 | +21.0% | 64,200 | 0.0% | 0.85% | +19.4% |
| Q4 2022 | $1,029,768 | +2.3% | 64,200 | 0.0% | 0.71% | +10.4% |
| Q3 2022 | $1,007,000 | -24.7% | 64,200 | 0.0% | 0.64% | -30.0% |
| Q2 2022 | $1,337,000 | -8.1% | 64,200 | 0.0% | 0.92% | +33.0% |
| Q1 2022 | $1,455,000 | +23.9% | 64,200 | 0.0% | 0.69% | +98.8% |
| Q4 2021 | $1,174,000 | -13.5% | 64,200 | 0.0% | 0.35% | -20.0% |
| Q3 2021 | $1,357,000 | +16.0% | 64,200 | 0.0% | 0.43% | +19.2% |
| Q2 2021 | $1,170,000 | – | 64,200 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |